BASSER CENTER FOR BRCA – PENN MEDICINE

So wonderful to read through the BASSER Progress report! Gives me such hope for our children’s future. IN 10 YEARS By 2030, Basser will continue to improve our understanding of BRCA, allowing us to overcome chemotherapy resistance, develop new targeted therapies for mutation carriers, and have better medications for managing metastatic breast cancer. We also…